PIGM
Basic information
Region (hg38): 1:160024953-160031990
Links
Phenotypes
GenCC
Source:
- hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency (Limited), mode of inheritance: AR
- hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency (Moderate), mode of inheritance: AR
- hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency (Supportive), mode of inheritance: AR
- hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Glycosylphosphatidylinositol biosynthesis defect 1 | AR | Biochemical; Hematologic; Neurologic; Pharmacogenomic | Medical treatment may be beneficial (eg, prophylactic oral anticoagulants to prevent thrombosis; sodium phenylbutyrate for seizure control); Awareness of coagulopathies may be beneficial in terms of medical management, especially in situations such as surgery; Hepatic-metabolized agents should be avoided | Biochemical; Hematologic; Neurologic | 16767100; 17442906; 19168132; 31445883 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PIGM gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 18 | ||||
missense | 64 | 67 | ||||
nonsense | 1 | |||||
start loss | 1 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 2 | 66 | 16 | 6 |
Variants in PIGM
This is a list of pathogenic ClinVar variants found in the PIGM region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-160030471-G-C | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | Uncertain significance (Jun 25, 2023) | ||
1-160030482-TTCTC-T | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency • not specified • PIGM-related disorder | Uncertain significance (Feb 22, 2024) | ||
1-160030523-T-G | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | Uncertain significance (Nov 15, 2022) | ||
1-160030541-T-C | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | Uncertain significance (Jul 12, 2022) | ||
1-160030547-A-G | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | Uncertain significance (Jun 23, 2023) | ||
1-160030548-G-C | not specified | Uncertain significance (Mar 06, 2023) | ||
1-160030590-T-C | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency • PIGM-related disorder | Benign (Jan 24, 2024) | ||
1-160030597-T-C | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | Likely benign (Oct 14, 2023) | ||
1-160030640-C-A | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | Uncertain significance (Feb 28, 2022) | ||
1-160030645-A-T | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | Benign (Jan 30, 2024) | ||
1-160030647-A-C | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | Uncertain significance (Sep 01, 2022) | ||
1-160030650-A-G | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | Uncertain significance (Feb 22, 2024) | ||
1-160030698-G-A | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | Benign (Apr 01, 2023) | ||
1-160030698-G-C | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency • not specified | Uncertain significance (Oct 27, 2023) | ||
1-160030723-G-A | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | Likely benign (Jul 07, 2020) | ||
1-160030739-T-G | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | Uncertain significance (Jun 30, 2022) | ||
1-160030741-G-A | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency • PIGM-related disorder | Benign/Likely benign (Aug 30, 2023) | ||
1-160030758-T-A | not specified | Uncertain significance (Aug 13, 2021) | ||
1-160030778-G-T | PIGM-related disorder | Uncertain significance (Aug 18, 2022) | ||
1-160030779-T-C | not specified | Uncertain significance (Dec 19, 2023) | ||
1-160030781-T-C | PIGM-related disorder | Uncertain significance (Dec 02, 2023) | ||
1-160030790-C-T | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency • not specified | Uncertain significance (May 10, 2024) | ||
1-160030802-AGGTCTCTGT-A | See cases | Uncertain significance (May 10, 2021) | ||
1-160030873-G-C | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | Likely benign (Aug 16, 2022) | ||
1-160030877-A-G | not specified | Uncertain significance (Jun 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PIGM | protein_coding | protein_coding | ENST00000368090 | 1 | 4322 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000539 | 0.699 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0811 | 215 | 212 | 1.02 | 0.0000103 | 2735 |
Missense in Polyphen | 72 | 79.781 | 0.90247 | 1063 | ||
Synonymous | 0.0922 | 90 | 91.1 | 0.988 | 0.00000463 | 893 |
Loss of Function | 0.957 | 8 | 11.5 | 0.695 | 5.05e-7 | 146 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Mannosyltransferase involved in glycosylphosphatidylinositol-anchor biosynthesis. Transfers the first alpha-1,4-mannose to GlcN-acyl-PI during GPI precursor assembly. {ECO:0000269|PubMed:11226175}.;
- Disease
- DISEASE: Glycosylphosphatidylinositol deficiency (GPID) [MIM:610293]: Autosomal recessive trait that results in a propensity to venous thrombosis and seizures. Deficiency is due to a point mutation in the regulatory sequences of PIGM that disrupts binding of the transcription factor SP1 to its cognate promoter motif, leading to a strong reduction of expression. {ECO:0000269|PubMed:16767100}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human);Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins
(Consensus)
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- loftool
- 0.675
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 34.6
Haploinsufficiency Scores
- pHI
- 0.0995
- hipred
- N
- hipred_score
- 0.239
- ghis
- 0.557
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.371
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pigm
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- GPI anchor biosynthetic process
- Cellular component
- endoplasmic reticulum membrane;integral component of membrane
- Molecular function
- transferase activity, transferring hexosyl groups